4 PREGENEN 11SS 17 21 TRIOL 3 20 DIONE DERIVATIVES FOR THE TREATMENT OF OCULAR CONDITIONS

摘要

The present invention relates to novel 4 pregenen 11 17 21 triol 3 20 dione derivatives processes for preparing them pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of glucocorticoid or mineralocorticoid receptors. The invention relates specifically to the use of these compounds and their pharmaceutical compositions to treat disorders associated with glucocorticoid or mineralocorticoid receptor modulation.